miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC.

Qu, Xuqin; Gao, Dezhen; Ren, Qingxia; Jiang, Xiufang; Bai, Jianhua; Sheng, Li

Qu, Xuqin; Gao, Dezhen; Ren, Qingxia; Jiang, Xiufang; Bai, Jianhua; Sheng, Li.

Afiliación

Qu X; Reproductive Center, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China.
Gao D; Department of Blood Transfusion, Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.
Ren Q; Clinical Laboratory, People's Hospital of Rizhao, Rizhao, Shandong 276826, P.R. China.
Jiang X; Department of Obstetrics, People's Hospital of Zhangqiu District, Jinan, Shandong 250200, P.R. China.
Bai J; Department of Obstetrics, People's Hospital of Zhangqiu District, Jinan, Shandong 250200, P.R. China.
Sheng L; Clinical Laboratory, Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

Oncol Lett ; 16(1): 853-860, 2018 Jul.

Article en En | MEDLINE | ID: mdl-29963155

Palabras clave

SPARC; cervical cancer; invasion; miR-211; migration; proliferation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article